Works matching DE "TRASTUZUMAB"

Results: 2932

Recent ADC Approvals and Their Impact on the Breast Cancer Space.

Published in:

Oncology (08909091), 2025, v. 39, n. 4, p. 138

By:

Iyengar, Neil M.

Publication type:

Article

Immune-enrichment Predicts Response to Trastuzumab.

Published in:: Oncology (08909091), 2014, v. 28, n. 7, p. III
Publication type:: Article

Cardiovascular Toxicity of Biologic Agents for Cancer Therapy.

Published in:

Oncology (08909091), 2014, v. 28, n. 6, p. 482

By:

BHAVE, MANALI;
AKHTER, NAUSHEEN;
ROSEN, STEVEN T.

Publication type:

Article

Cardiovascular Toxicity of Newer Chemotherapeutic Agents: The Heart of the Matter.

Published in:

Oncology (08909091), 2014, v. 28, n. 6, p. 493

By:

SHAIKH, AMIR Y.;
McGUINESS, MATTHEW E.;
SHIH, JEFFREY A.

Publication type:

Article

HER2-Positive Breast Cancer: The Story Goes On.

Published in:

Oncology (08909091), 2014, v. 28, n. 4, p. 290

By:

CHAMBERLIN, MARY D.;
KAUFMAN, PETER A.

Publication type:

Article

HER2-Directed Therapy for Metastatic Breast Cancer.

Published in:

Oncology (08909091), 2013, v. 27, n. 3, p. 166

By:

Jelovac, Danijela;
Emens, Leisha A.

Publication type:

Article

Subcutaneous Trastuzumab (Herceptin) Injection Shows Promise.

Published in:: Oncology (08909091), 2012, v. 26, n. 9, p. 873
Publication type:: Article

What Is the Current Standard of Care for Anti-HER2 Neoadjuvant Therapy in Breast Cancer?

Published in:

Oncology (08909091), 2012, v. 26, n. 1, p. 20

By:

VON MINCKWITZ, GUNTER;
LOIBL, SIBYLLE;
UNTCH, MICHAEL

Publication type:

Article

HER2-Targeted Therapies: How Far We've Come--and Where We're Headed.

Published in:

Oncology (08909091), 2011, v. 25, n. 5, p. 425

By:

DAVIDSON, NANCY E.

Publication type:

Article

Targeting Alternative Pathways in HER2-Positive Breast Cancer.

Published in:

Oncology (08909091), 2010, v. 24, n. 5, p. 415

By:

Rastogi, Priya

Publication type:

Article

HER2-Positive Breast Cancer: Beyond Trastuzumab.

Published in:

Oncology (08909091), 2010, v. 24, n. 5, p. 410

By:

Murphy, Conleth G.;
Fornier, Monica

Publication type:

Article

Trastuzumab Resistance: Bringing Tailored Therapy to the Clinic.

Published in:

Oncology (08909091), 2008, v. 22, n. 11, p. 1259

By:

Bedard, Philippe L.;
Piccart-Gebhart, Martine J.

Publication type:

Article

Trastuzumab: Mechanisms of Resistance and Therapeutic Opportunities.

Published in:

Oncology (08909091), 2008, v. 22, n. 11, p. 1250

By:

Calabrich, Aknar;
Fernandes, Gustvao Dos Santos;
Katz, Artur

Publication type:

Article

Breast Cancer Study Establishes New Model for Global Clinical Trials.

Published in:: Oncology (08909091), 2008, v. 22, n. 3, p. 257
Publication type:: Article

Study Supports Activity of Gemcitabine in Treatment of Early-Stage Breast Cancer.

Published in:: Oncology (08909091), 2007, v. 21, n. 11, p. 1285
Publication type:: Article

What Progress Have We Made in Managing Inflammatory Breast Cancer?

Published in:

Oncology (08909091), 2007, v. 21, n. 6, p. 673

By:

Dawood, Shaheenah;
Cristofanilli, Massimo

Publication type:

Article

Landmark Lapatinib Data Published.

Published in:: Oncology (08909091), 2007, v. 21, n. 1, p. 108
Publication type:: Article

Trastuzumab and Beyond: New Possibilities for the Treatment of HER2-Positive Breast Cancer.

Published in:

Oncology (08909091), 2006, v. 20, n. 14, p. 1763

By:

Morris, Shannon R.;
Carey, Lisa A.

Publication type:

Article

HER2-Positive Breast Cancer: Remaining Challenges.

Published in:

Oncology (08909091), 2006, v. 20, n. 14, p. 1775

By:

Marcom, P. Kelly;
Verrier, Carmel S.

Publication type:

Article

Trastuzumab: Further Considerations.

Published in:

Oncology (08909091), 2006, v. 20, n. 14, p. 1771

By:

Shaheenah Dawood;
Buzdar, Aman U.

Publication type:

Article

Boosting Killer Cells Might Improve Breast Cancer Drug.

Published in:: Oncology (08909091), 2006, v. 20, n. 9, p. 1114
Publication type:: Article

HERA Trial Follow-up Continues to Demonstrate Significant Patient Benefits From Herceptin.

Published in:: Oncology (08909091), 2006, v. 20, n. 9, p. 1092
Publication type:: Article

Serum HER2/neu Change Predicts Clinical Outcome to Trastuzumab-Based Therapy.

Published in:: Oncology (08909091), 2006, v. 20, n. 9, p. 1094
Publication type:: Article

A Woman With Primary Breast Cancer and a Solitary Sternal Metastasis.

Published in:

Oncology (08909091), 2006, v. 20, n. 9, p. 1068

By:

Mentel, Alexander;
Urquhart, Alexander;
Borges, Virginia;
Rabinovitch, Rachel;
Singh, Meenakshi;
Robinson, William;
Seligman, Paul;
Finlayson, Christina;
Elias, Anthony

Publication type:

Article

Understanding Breast Cancer Management and Treatment.

Published in:: Oncology (08909091), 2006, v. 20, n. 9, p. 975
Publication type:: Article

Fourth Phase III Study Shows Trastuzumab/Chemotherapy Improved Disease-Free Survival in Breast Cancer Patients.

Published in:: Oncology (08909091), 2005, v. 19, n. 11, p. 1
Publication type:: Article

Oncology NEWS INTERNATIONAL.

Published in:: Oncology (08909091), 2005, v. 19, n. 7, p. 862
Publication type:: Article

Trastuzumab Plus Chemotherapy Improves Survival in Early-Stage HER2-Positive Breast Cancer Patients.

Published in:: Oncology (08909091), 2005, v. 19, n. 7, p. 851
Publication type:: Article

Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique.

Published in:

European Journal of Health Economics, 2014, v. 15, n. 1, p. 93, doi. 10.1007/s10198-013-0459-2

By:

Parkinson, Bonny;
Pearson, Sallie-Anne;
Viney, Rosalie

Publication type:

Article

Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab.

Published in:

European Journal of Health Economics, 2012, v. 13, n. 5, p. 589, doi. 10.1007/s10198-011-0323-1

By:

Delea, Thomas;
Tappenden, Paul;
Sofrygin, Oleg;
Browning, Dominy;
Amonkar, Mayur;
Karnon, Jon;
Walker, Mel;
Cameron, David

Publication type:

Article

Breast Cancer Care During COVID-19 Pandemic.

Published in:

2020

By:

Agrawal, Himanshu;
Yelamanchi, Raghav;
Gupta, Nikhil;
Durga, C. K.

Publication type:

Letter

HER2 Expression in Gastric and Gastroesophageal Cancer: Report from a Tertiary Care Hospital in North India.

Published in:

Indian Journal of Surgery, 2015, v. 77, p. 447, doi. 10.1007/s12262-013-0871-y

By:

Mishra, RR;
Tewari, Mallika;
Kumar, Akhileshwar;
Shukla, Hari;
Kumar, Mohan

Publication type:

Article

Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting.

Published in:

Chemistry - A European Journal, 2023, v. 29, n. 11, p. 1, doi. 10.1002/chem.202202491

By:

Hashad, Rania A.;
Jap, Edwina;
Casey, Joanne L.;
Candace Ho, Y. T.;
Wright, Alexander;
Thalmann, Claudia;
Sleeman, Mark;
Lupton, David W.;
Hagemeyer, Christoph E.;
Cryle, Max J.;
Robert, Remy;
Alt, Karen

Publication type:

Article

Frontispiece: Investigating Ugi/Passerini Multicomponent Reactions for the Site‐Selective Conjugation of Native Trastuzumab.

Published in:

Chemistry - A European Journal, 2020, v. 26, n. 61, p. 1, doi. 10.1002/chem.202086163

By:

Sornay, Charlotte;
Hessmann, Steve;
Erb, Stéphane;
Dovgan, Igor;
Ehkirch, Anthony;
Botzanowski, Thomas;
Cianférani, Sarah;
Wagner, Alain;
Chaubet, Guilhem

Publication type:

Article

Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer.

Published in:

Angewandte Chemie, 2016, v. 128, n. 26, p. 7646, doi. 10.1002/ange.201601902

By:

Cao, Yu;
Rodgers, David T.;
Du, Juanjuan;
Ahmad, Insha;
Hampton, Eric N.;
Ma, Jennifer S. Y.;
Mazagova, Magdalena;
Choi, Sei‐hyun;
Yun, Hwa Young;
Xiao, Han;
Yang, Pengyu;
Luo, Xiaozhou;
Lim, Reyna K. V.;
Pugh, Holly M.;
Wang, Feng;
Kazane, Stephanie A.;
Wright, Timothy M.;
Kim, Chan Hyuk;
Schultz, Peter G.;
Young, Travis S.

Publication type:

Article

Rational Design of a Humanized Glucagon-Like Peptide-1 Receptor Agonist Antibody.

Published in:

Angewandte Chemie, 2015, v. 127, n. 7, p. 2154, doi. 10.1002/ange.201410049

By:

Zhang, Yong;
Zou, Huafei;
Wang, Ying;
Caballero, Dawna;
Gonzalez, Jose;
Chao, Elizabeth;
Welzel, Gus;
Shen, Weijun;
Wang, Danling;
Schultz, Peter G.;
Wang, Feng

Publication type:

Article

Antikörper-Wirkstoff-Konjugate: ein neues Konzept in der Krebstherapie.

Published in:

Angewandte Chemie, 2014, v. 126, n. 15, p. 3872, doi. 10.1002/ange.201307628

By:

Chari, Ravi V. J.;
Miller, Michael L.;
Widdison, Wayne C.

Publication type:

Article

High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 2, p. 131, doi. 10.1007/s10147-011-0269-4

By:

Horio, Akiyo;
Fujita, Takashi;
Hayashi, Hironori;
Hattori, Masaya;
Kondou, Naoto;
Yamada, Mai;
Adachi, Eri;
Ushio, Aya;
Gondou, Naomi;
Sueta, Aiko;
Yatabe, Yasushi;
Iwata, Hiroji

Publication type:

Article

Serum HER2 levels determined by two methods in patients with metastatic breast cancer.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 1, p. 55, doi. 10.1007/s10147-011-0253-z

By:

Hayashi, Naoki;
Nakamura, Seigo;
Tokuda, Yasuharu;
Yagata, Hiroshi;
Yoshida, Atsushi;
Ota, Hidekazu;
Hortobagyi, Gabriel;
Cristofanilli, Massimo;
Ueno, Naoto

Publication type:

Article

Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes.

Published in:

International Journal of Clinical Oncology, 2011, v. 16, n. 6, p. 623, doi. 10.1007/s10147-011-0231-5

By:

Matsubara, Yoshihiro;
Sakabayashi, Satomi;
Nishimura, Tsutomu;
Ishida, Takanori;
Ohuchi, Noriaki;
Teramukai, Satoshi;
Fukushima, Masanori

Publication type:

Article

Time to first tumor progression as a predictor of efficacy of continued treatment with trastuzumab beyond progression in human epidermal growth factor receptor 2-positive metastatic breast cancer.

Published in:

International Journal of Clinical Oncology, 2011, v. 16, n. 6, p. 694, doi. 10.1007/s10147-011-0251-1

By:

Hayashi, Mitsuhiro;
Okumura, Yasuhiro;
Osako, Tomofumi;
Toyozumi, Yasuo;
Arima, Nobuyuki;
Iwase, Hirotaka;
Nishimura, Reiki

Publication type:

Article

A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 6, p. 615, doi. 10.1007/s10147-010-0093-2

By:

Shigematsu, Hideo;
Nakamura, Yoshiaki;
Tanaka, Kimihiro;
Shiotani, Satoko;
Koga, Chinami;
Kawaguchi, Hidetoshi;
Nishimura, Sumiko;
Taguchi, Kenichi;
Nishiyama, Kenichi;
Ohno, Shinji

Publication type:

Article

Treatment strategy for HER2-positive breast cancer.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 4, p. 335, doi. 10.1007/s10147-010-0107-0

By:

Mukai, Hirofumi

Publication type:

Article

Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer.

Published in:

International Journal of Clinical Oncology, 2009, v. 14, n. 5, p. 431, doi. 10.1007/s10147-009-0898-z

By:

Ishihara, Mikiya;
Mukai, Hirofumi;
Nagai, Shunji;
Mukohara, Toru

Publication type:

Article

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer.

Published in:

International Journal of Clinical Oncology, 2009, v. 14, n. 1, p. 48, doi. 10.1007/s10147-008-0797-8

By:

Ono, Makiko;
Ando, Masashi;
Yunokawa, Mayu;
Nakano, Eriko;
Yonemori, Kan;
Matsumoto, Koji;
Kouno, Tsutomu;
Shimizu, Chikako;
Tamura, Kenji;
Katsumata, Noriyuki;
Fujiwara, Yasuhiro

Publication type:

Article

Trastuzumab and breast cancer: developments and current status.

Published in:

International Journal of Clinical Oncology, 2006, v. 11, n. 3, p. 199, doi. 10.1007/s10147-006-0575-4

By:

Tokunaga, Eriko;
Oki, Eiji;
Nishida, Kojiro;
Koga, Tadashi;
Egashira, Akinori;
Morita, Masaru;
Kakeji, Yoshihiro;
Maehara, Yoshihiko

Publication type:

Article

Antibodies as molecular target-based therapy: trastuzumab.

Published in:

International Journal of Clinical Oncology, 2003, v. 8, n. 4, p. 224, doi. 10.1007/s10147-003-0334-8

By:

Tokuda, Yntaka

Publication type:

Article

Population pharmacokinetics and exposure–response relationship of trastuzumab and bevacizumab in early-stage breast cancer.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 12, p. 1861, doi. 10.1007/s00228-021-03179-w

By:

Petitcollin, A.;
Azzopardi, N.;
Pierga, J. Y.;
Ternant, D.;
Navarro-Teulon, I.;
Desvignes, C.;
Mouret-Reynier, M. A.;
Coudert, B.;
Paintaud, G.

Publication type:

Article

Uptake of biosimilar trastuzumab in Denmark compared with other European countries: a comparative study and discussion of factors influencing implementation and uptake of biosimilars.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1495, doi. 10.1007/s00228-021-03155-4

By:

Azuz, Samuel;
Newton, Max;
Bartels, Dorthe;
Poulsen, Birgitte Klindt

Publication type:

Article

Use of population approach non-linear mixed effects models in the evaluation of biosimilarity of monoclonal antibodies.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 11, p. 1343, doi. 10.1007/s00228-016-2101-6

By:

Reijers, Joannes;
Donge, T.;
Schepers, F.;
Burggraaf, J.;
Stevens, J.

Publication type:

Article